The Guest Editors have assembled expert authors to provide clinical reviews on the current knowledge about the impact of neurologic disease on the urinary tract. Specific articles are devoted to the following topics: The Cost of Care in Neurogenic Lower Urinary Tract Dysfunction; How to Measure Quality of Life Concerns in Patients with Neurogenic Lower Urinary tract Dysfunction; Long-term Complications of the Neurogenic Bladder; Surveillance Strategies for Patients with Neurogenic Bladder; Establishing a Multi-disciplinary Approach to the Management of Neurologic Disease affecting the Urinary Tract; Evaluation and Lifetime Management of the Urinary Tract in Patients with Myelomeningocele; Contemporary Treatment of Post-Stroke Lower Urinary Tract Dysfunction; Parkinson’s Disease and its Effect on the Lower Urinary Tract: Evaluation of Complications and Treatment Strategies; Management of the Neurogenic Bladder in Patients with Multiple Sclerosis; Identifying the High-Risk Neurogenic Bladder after Spinal cord Injury; Peripheral and Sacral Neuromodulation in the Treatment of Neurogenic Lower Urinary Tract Dysfunction; Disease-specific Outcomes of Botulinum; Toxin Injections for Neurogenic Detrusor Overactivity; Surgical Management of Neurogenic Lower Urinary Tract Dysfunction; Tissue Engineering Strategies for Neurogenic Lower Urinary Tract Dysfunction; Mending Gaps in Knowledge: Collaboratives in Neurogenic Bladder Research. Readers will be able to employ this clinical information in the treatment and management of their neurologic patients.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. CME Accreditation Page - p. iii 6. Contributors - p. v 7. Forthcoming Issues - p. xiv 8. Foreword - p. xv 9. Preface - p. xvii 10. Understanding the Economic Impact of Neurogenic Lower Urinary Tract Dysfunction - p. 333 11. How to Measure Quality-of-Life Concerns in Patients with Neurogenic Lower Urinary Tract Dysfunction - p. 345 12. Long-Term Complications of the Neurogenic Bladder - p. 355 13. Surveillance Strategies for Neurogenic Lower Urinary Tract Dysfunction - p. 367 14. Establishing a Multidisciplinary Approach to the Management of Neurologic Disease Affecting the Urinary Tract - p. 377 15. Evaluation and Lifetime Management of the Urinary Tract in Patients with Myelomeningocele - p. 391 16. Contemporary Evaluation and Treatment of Poststroke Lower Urinary Tract Dysfunction - p. 403 17. Parkinson’s Disease and Its Effect on the Lower Urinary Tract: Evaluation of Complications and Treatment Strategies - p. 415 18. Chronic Urinary Retention in Multiple Sclerosis Patients: Physiology, Systematic Review of Urodynamic Data, and Recommendations for Care - p. 429 19. Identifying Patients with High-Risk Neurogenic Bladder: Beyond Detrusor Leak Point Pressure - p. 441 20. Peripheral and Sacral Neuromodulation in the Treatment of Neurogenic Lower Urinary Tract Dysfunction - p. 453 21. Disease-Specific Outcomes of Botulinum Toxin Injections for Neurogenic Detrusor Overactivity - p. 463 22. Surgical Management of Neurogenic Lower Urinary Tract Dysfunction - p. 475 23. New Frontiers of Basic Science Research in Neurogenic Lower Urinary Tract Dysfunction - p. 491 24. Mending Gaps in Knowledge: Collaborations in Neurogenic Bladder Research - p. 507
No hay muestra disponible
No hay ficha técnica disponible
The Guest Editors have assembled expert authors to provide clinical reviews on the current knowledge about the impact of neurologic disease on the urinary tract. Specific articles are devoted to the following topics: The Cost of Care in Neurogenic Lower Urinary Tract Dysfunction; How to Measure Quality of Life Concerns in Patients with Neurogenic Lower Urinary tract Dysfunction; Long-term Complications of the Neurogenic Bladder; Surveillance Strategies for Patients with Neurogenic Bladder; Establishing a Multi-disciplinary Approach to the Management of Neurologic Disease affecting the Urinary Tract; Evaluation and Lifetime Management of the Urinary Tract in Patients with Myelomeningocele; Contemporary Treatment of Post-Stroke Lower Urinary Tract Dysfunction; Parkinson’s Disease and its Effect on the Lower Urinary Tract: Evaluation of Complications and Treatment Strategies; Management of the Neurogenic Bladder in Patients with Multiple Sclerosis; Identifying the High-Risk Neurogenic Bladder after Spinal cord Injury; Peripheral and Sacral Neuromodulation in the Treatment of Neurogenic Lower Urinary Tract Dysfunction; Disease-specific Outcomes of Botulinum; Toxin Injections for Neurogenic Detrusor Overactivity; Surgical Management of Neurogenic Lower Urinary Tract Dysfunction; Tissue Engineering Strategies for Neurogenic Lower Urinary Tract Dysfunction; Mending Gaps in Knowledge: Collaboratives in Neurogenic Bladder Research. Readers will be able to employ this clinical information in the treatment and management of their neurologic patients.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. CME Accreditation Page - p. iii 6. Contributors - p. v 7. Forthcoming Issues - p. xiv 8. Foreword - p. xv 9. Preface - p. xvii 10. Understanding the Economic Impact of Neurogenic Lower Urinary Tract Dysfunction - p. 333 11. How to Measure Quality-of-Life Concerns in Patients with Neurogenic Lower Urinary Tract Dysfunction - p. 345 12. Long-Term Complications of the Neurogenic Bladder - p. 355 13. Surveillance Strategies for Neurogenic Lower Urinary Tract Dysfunction - p. 367 14. Establishing a Multidisciplinary Approach to the Management of Neurologic Disease Affecting the Urinary Tract - p. 377 15. Evaluation and Lifetime Management of the Urinary Tract in Patients with Myelomeningocele - p. 391 16. Contemporary Evaluation and Treatment of Poststroke Lower Urinary Tract Dysfunction - p. 403 17. Parkinson’s Disease and Its Effect on the Lower Urinary Tract: Evaluation of Complications and Treatment Strategies - p. 415 18. Chronic Urinary Retention in Multiple Sclerosis Patients: Physiology, Systematic Review of Urodynamic Data, and Recommendations for Care - p. 429 19. Identifying Patients with High-Risk Neurogenic Bladder: Beyond Detrusor Leak Point Pressure - p. 441 20. Peripheral and Sacral Neuromodulation in the Treatment of Neurogenic Lower Urinary Tract Dysfunction - p. 453 21. Disease-Specific Outcomes of Botulinum Toxin Injections for Neurogenic Detrusor Overactivity - p. 463 22. Surgical Management of Neurogenic Lower Urinary Tract Dysfunction - p. 475 23. New Frontiers of Basic Science Research in Neurogenic Lower Urinary Tract Dysfunction - p. 491 24. Mending Gaps in Knowledge: Collaborations in Neurogenic Bladder Research - p. 507
No hay muestra disponible
No hay ficha técnica disponible
